CAS: 2227425-05-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PF-06869206 REF: IN-DA01EOI0CAS: 2227425-05-8 | % | To inquire | Fri 29 Nov 24 |
 | PF-06869206 REF: TM-TQ0011CAS: 2227425-05-8 | 99.37% - 99.79% | To inquire | Thu 05 Dec 24 |
 | PF-06869206 REF: 3D-CPD42505CAS: 2227425-05-8 | Min. 95% | To inquire | Thu 09 Jan 25 |
Ref: IN-DA01EOI0
| 5mg | 154.00 € | ||
| 25mg | 500.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 29 Nov 2024
PF-06869206
CAS:2227425-05-8
PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).
Formula:
C15H14ClF3N4O2
Purity:
99.37% - 99.79%
Color and Shape:
Solid
Molecular weight:
374.75
Ref: TM-TQ0011
| 5mg | 39.00 € | ||
| 10mg | 63.00 € | ||
| 25mg | 123.00 € | ||
| 50mg | 206.00 € | ||
| 100mg | To inquire | ||
| 1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
PF-06869206
CAS:2227425-05-8
PF-06869206 is a binder that binds to the parathyroid hormone receptor and inhibits its activity. …
Formula:
C15H14ClF3N4O2
Purity:
Min. 95%
Molecular weight:
374.75 g/mol
Ref: 3D-CPD42505
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
